Back to search
FDAFDA · Food and drugs·Recall number Z-3091-2026

GRANUFLO Dry Acid Concentrate: Product Numbers: 0FD2251-3B; 0FD3251-3B; Dry Acid Concentrate for Bicarbonate Hemodialysis

Published September 9, 2026 · Recall initiated: July 14, 2026

Summary

FDA records medical device Class II recall Z-3091-2026, published September 9, 2026 and initiated July 14, 2026. Recalling firm: Fresenius Medical Care Renal Therapies Group, LLC; Status: Ongoing; Reported quantity: 27,216 cs; 2,316 ea; Lot: 1) 0FD2251-3B, UDI/DI 00840861101535, Lot Numbers: 26AXGF015, 26AXGF016, 26AXGF017, 26BXGF008, 26BXGF009; 2) 0FD3251-3B, UDI/DI 00840861101597, Lot Numbers: 26AXGF014, 26AXGF018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Complaints of blue-green discoloration in product

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Fresenius Medical Care Renal Therapies Group, LLC
Distributor
Worldwide distribution - US Nationwide and the country of Mexico.
Lot
1) 0FD2251-3B, UDI/DI 00840861101535, Lot Numbers: 26AXGF015, 26AXGF016, 26AXGF017, 26BXGF008, 26BXGF009; 2) 0FD3251-3B, UDI/DI 00840861101597, Lot Numbers: 26AXGF014, 26AXGF018.
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was GRANUFLO Dry Acid Concentrate: Product Numbers: 0FD2251-3B; 0FD3251-3B; Dry Acid Concentrate for Bicarbonate Hemodialysis recalled?

Yes. FDA published recall Z-3091-2026 on September 9, 2026. Reported hazard: Complaints of blue-green discoloration in product

What should I do if I have this product?

Voluntary: Firm initiated · Letter